LCMS using a hybrid quadrupole time of flight mass spectrometer for impurity identification during process chemical development of a novel integrase inhibitor.

[1]  D. Hazuda,et al.  Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection. , 2008, Journal of medicinal chemistry.

[2]  V. Summa,et al.  4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[3]  E. Acosta,et al.  A sensitive HPLC-MS-MS method for the determination of raltegravir in human plasma. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  J. Poirier,et al.  Quantification of the HIV-integrase inhibitor raltegravir (MK-0518) in human plasma by high-performance liquid chromatography with fluorescence detection. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  R. Plumb,et al.  The rapid detection and identification of the impurities of simvastatin using high resolution sub 2 microm particle LC coupled to hybrid quadrupole time of flight MS operating with alternating high-low collision energy. , 2007, Journal of separation science.

[6]  E. Woolf,et al.  Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid-liquid extraction and HPLC-MS/MS. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  Srinivas Tummala,et al.  Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry. , 2006, Chemical reviews.

[8]  Mario Cindrić,et al.  Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry. , 2005, Journal of pharmaceutical and biomedical analysis.

[9]  Hans-Jürgen Federsel,et al.  Searching for scalable processes: addressing the challenges in times of increasing complexity. , 2003, Current opinion in drug discovery & development.

[10]  P. Reider,et al.  Stereoselective synthesis from a process research perspective. , 2002, Drug discovery today.

[11]  J. Langridge,et al.  The use of liquid chromatography combined with a quadrupole time‐of‐flight analyser for the identification of trace impurities in drug substance , 1997 .